David Margulies

Dr Margulies has been active in the healthtech industry since the early 1980s. He co-founded and led BRS Medical, later acquired by WB Saunders and, ultimately, Elsevier North Holland. While CIO at Boston Children’s Hospital, he led the design of software that was acquired by Cerner to be the basis of Cerner’s EMR, becoming EVP, Chief Scientist, and a BOD member at Cerner. He co-founded and was a Director of CareInsite (acquired by WebMD) and co-founded and was CEO and Chairman of Correlagen Diagnostics (acquired by LabCorp).

‍

Dr. Margulies was most recently VP of Strategy at Boston Children’s Hospital where he led development of the institution’s genomic medicine strategy and later co-founded and was Chairman of Q-State Biosciences. Over the years he has served on numerous public and private boards including D2 Hawkeye (acquired by Verisk), ObMedical (acquired by Philips), Circulation (acquired by Logisticare), Generation Health (acquired by CVS), Claritas Genomics (acquired by Q-State Biosciences), and Commonwealth Care Alliance.

‍

He currently serves as Director for Travera. Dr. Margulies received his BA from Amherst College and his MD from Harvard Medical School. He completed his clinical training and board certification in Internal Medicine at Columbia College of Physicians and Surgeons. Dr. Margulies recently retired from the faculties of Genetics and Bioinformatics at Harvard Medical School.